Orlando, FL (PRWEB) September 27, 2016 -- The U.S. Food and Drug Administration has approved the use of Morning After™ a new brand of emergency contraceptive, as a non-prescription product for all child-bearing women. This action complies with a federal court’s decision to make emergency contraceptives available as an over-the-counter (OTC) drug without age or point-of-sale restrictions.
Morning After™ is an emergency contraceptive that greatly reduces the chance of pregnancy following unprotected sex or a suspected contraceptive failure such as a broken condom. Morning After is a single-dose pill, 1.5 mg tablet, that is effective in decreasing the chance of pregnancy and should be taken as soon as possible within three days after unprotected sex.
The FDA has fulfilled its commitment to the court by promptly completing its swift review, approval, and labeling requirements – giving way for Rapha Pharmaceuticals to place Morning After™ on retail shelves nationwide.
• Morning After™ will be available at over 700 local pharmacy and stores beginning September 19, 2016.
• With this approval, the product will be available without a prescription and without an ID.
• Over-the-counter access to Morning After can further decrease the rate of unintended pregnancies by giving women the right to make informed decisions about their own health.
“Morning After contains higher levels of a hormone found in many types of daily use birth control pills and works in a similar way to these contraceptive pills by stopping ovulation and therefore preventing pregnancy,” said Joseph Santos. M.D., director of Rapha Pharmaceuticals’ women’s health division.
The initial launch of the Morning After™ brand will be to many local pharmacy locations through the southeast states (including FL, GA, AL, TX, LA, KY, MS, AR, SC, and NC). If you do not see Morning After available at your local pharmacy, put through a request so that this affordable emergency contraceptive becomes available.
"We are very excited to get this product out on the market and offer an extremely affordable alternative for women of all ages who are looking towards preventing pregnancy," says Michael Shoffner, President of Rapha Pharmaceuticals.
Source: Rapha Pharmaceuticals, Inc.
Rapha Pharmaceuticals, Inc. is improving the quality of life for women of all ages with innovate products specially formulated for women. We’re doing this with a diverse portfolio of solutions for women’s daily health and wellness concerns.
Morning After™, http://www.buymorningafter.com/, +1 (407) 362-7638, [email protected]